indirubin has been researched along with Mastitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YY; Guo, AZ; Hu, CM; Lai, JL; Liu, C; Liu, RN; Liu, YH; Qi, MP; Zhou, QG; Zhu, XF | 1 |
| Chen, YY; Ge, P; Guo, AZ; He, CF; Hu, CM; Lai, JL; Liu, C; Liu, YH; Peng, YC | 1 |
2 other study(ies) available for indirubin and Mastitis
| Article | Year |
|---|---|
Indirubin Inhibits LPS-Induced Inflammation via TLR4 Abrogation Mediated by the NF-kB and MAPK Signaling Pathways.
Topics: Animals; Cytokines; Dose-Response Relationship, Drug; Female; Indoles; Inflammation; Inflammation Mediators; Lipopolysaccharides; MAP Kinase Signaling System; Mastitis; Mice; NF-kappa B; Signal Transduction; Toll-Like Receptor 4 | 2017 |
Indirubin Treatment of Lipopolysaccharide-Induced Mastitis in a Mouse Model and Activity in Mouse Mammary Epithelial Cells.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Cell Survival; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Female; Granulocyte Colony-Stimulating Factor; Humans; Indoles; Interleukin-1beta; Interleukin-3; Interleukin-6; Lipopolysaccharides; Male; Mammary Glands, Human; Mastitis; Mice; Recombinant Fusion Proteins; Signal Transduction; Tumor Necrosis Factor-alpha | 2017 |